First Report of the Four Year Clinical Results of The ABSORB Trial Evaluating the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Patients with de Novo Native Coronary Artery Lesions

[摘要]

[发布日期] 2013-10-29